DBV Technologies (DBVT) Long-Term Investments (2015 - 2019)
DBV Technologies (DBVT) posted quarterly Long-Term Investments of $18.8 million for Q4 2019, up 173.3% year-on-year from $6.9 million in Q4 2018, and up 168.36% on a QoQ basis from $7.0 million in Q2 2019.
DBV Technologies (DBVT) Long-Term Investments (2015 - 2019) Analysis & Trends
DBV Technologies (DBVT) has reported Long-Term Investments for 5 consecutive years, with $18.8 million the latest figure, recorded in Q4 2019.
- Quarterly Long-Term Investments rose 173.3% year-over-year to $18.8 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $18.8 million (up 173.3% YoY) and the FY2019 annual result came in at $18.8 million, up 173.3% from the prior year.
- Long-Term Investments rose to $18.8 million in Q4 2019 per DBVT's latest filing, from $7.0 million in the prior quarter.
- Over the last five years, Long-Term Investments for DBVT reached as high as $471.1 million in Q4 2015 and fell as low as $4.3 million in Q4 2017.
- A 5-year average of $147.5 million and a median of $12.9 million in 2019 frame the typical range for Long-Term Investments.
- Annual changes were most pronounced in 2017 — Long-Term Investments plunged 98.85% — and 2019, when it jumped 173.3%.
- Year by year, Long-Term Investments stood at $471.1 million in 2015, then declined by 20.05% to $376.7 million in 2016, then tumbled by 98.85% to $4.3 million in 2017, then jumped by 57.93% to $6.9 million in 2018, then soared by 173.3% to $18.8 million in 2019.
- According to Business Quant data, Long-Term Investments over the past three periods registered $18.8 million, $7.0 million, and $6.9 million for Q4 2019, Q2 2019, and Q4 2018 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 505,194.89 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 5.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.79 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | DBV Technologies | 267.50 Mn | 92.60 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 18.76 Mn |
| Jun 30, 2019 | 6.99 Mn |
| Dec 31, 2018 | 6.87 Mn |
| Dec 31, 2017 | 4.35 Mn |
| Dec 31, 2016 | 376.66 Mn |
| Dec 31, 2015 | 471.10 Mn |